Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · IEX Real-Time Price · USD
3.200
-0.050 (-1.54%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $180.78 million as of July 2, 2024. Its market cap has decreased by -43.11% in one year.
Market Cap
180.78M
Enterprise Value
-87.76M
1-Year Change
-43.11%
Ranking
Category
Stock Price
$3.20
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $1.08B to $180.78M, a decrease of -83.20%. That is a compound annual growth rate of -42.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 183.60M | 23.72% |
| Dec 29, 2023 | 148.40M | -74.13% |
| Dec 30, 2022 | 573.60M | -51.87% |
| Dec 31, 2021 | 1.19B | 10.72% |
| Mar 26, 2021 | 1.08B | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MultiPlan | 183.79M |
| Zevra Therapeutics | 183.29M |
| Sera Prognostics | 182.67M |
| Inogen | 181.78M |
| OptimizeRx | 181.60M |
| Biodesix | 178.49M |
| Shattuck Labs | 178.32M |
| P3 Health Partners | 178.18M |